Parkinson Disease, Idiopathic Clinical Trials
2 recruiting trials for Parkinson Disease, Idiopathic. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Parkinson Disease, Idiopathic clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Università degli Studi dell'Insubria (1), Kezhong Zhang (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Mediterranean Diet (behavioral, 1 trial), followed by taVNS real stimulation, taVNS sham stimulation.
Track Parkinson Disease, Idiopathic trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Mediterranean Diet Effects on Parkinson's Disease
Currently, there are no disease-modifying treatments for Parkinson's disease (PD), the second most common neurodegenerative disorder worldwide, making it crucial to find...
Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
This study is a randomized, double-blind, controlled trial exploring the effects of long-term taVNS intervention in patients with early-stage Parkinson's disease.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Parkinson Disease, Idiopathic, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Parkinson Disease, Idiopathic, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Parkinson Disease, Idiopathic, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.